ADVERTISEMENT
ADVERTISEMENT

D At California Biotech Firm

California Biotech Firm Author: KAREN YOUNG KREEGER Igor Gonda, 47, assumed the newly created position of vice president of research and development at Aradigm Corp., a privately held biotech firm in Hayward, Calif., on September 25. Gonda is leaving his post as senior scientist and group leader of pharmaceutics at South San Francisco, Calif., biotech giant Genentech Inc. in order to develop new drug-delivery systems at the company. Aradigm currently employs about 25 scientists. Gonda will be

Karen Young Kreeger

California Biotech Firm Author: KAREN YOUNG KREEGER

Igor Gonda, 47, assumed the newly created position of vice president of research and development at Aradigm Corp., a privately held biotech firm in Hayward, Calif., on September 25. Gonda is leaving his post as senior scientist and group leader of pharmaceutics at South San Francisco, Calif., biotech giant Genentech Inc. in order to develop new drug-delivery systems at the company.

Aradigm currently employs about 25 scientists. Gonda will be in charge of about half of them. "To have the opportunity to lead the research group in such a unique company is very attractive to me," he says. He adds that he is making the move so he can pursue what intrigues him the most scientifically-the design of aerosol-delivery systems for the treatment of respiratory diseases.

"The most exciting aspect for me in my new job will be to bring together what the...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT